Previous 10 | Next 10 |
SEATTLE, June 21, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 600 employers and millions of members, today announced that it will release fiscal first quarter 2023 financial results on Thursday, June 30, 2022, after the market closes. ...
Gainers: Rent the Runway (RENT) +10%. BioAtla (BCAB) +9%. Adaptive Biotechnologies Corporation (ADPT) +5%. Accolade (ACCD) +5%. Nurix Therapeutics (NRIX) +5%. Losers: DocuSign (DOCU) -23%. Stitch Fix (SFIX) -16%. Comtech Telecommunications (CMTL) -15%. View (VIEW) -12%. DBV Te...
SEATTLE, June 02, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will participate in the following upcoming investor conferences. A webcast and replay of each event will be available at ir.accolade.com. Wednesday, June 8 at 4:10 pm ET . Stifel 202...
Gainers: Fanhua (FANH) +7%. Ocular Therapeutix (OCUL) +5%. ThredUp (TDUP) +5%. Cara Therapeutics (CARA) +3%. LegalZoom.com (LZ) +3%. Losers: Eton Pharmaceuticals (ETON) -21%. Allakos (ALLK) -7%. Accolade (ACCD) -5%. Sono Group (SEV) -5%. FTC Solar (FTCI) -4%. For furth...
Accolade Expands Mental Health Integrated Care Offering to Adolescents and Teens PR Newswire Accolade and Headspace Health to increase access to preventative resources and mental health services for adolescents and teens amid national mental health crisis SEA...
SEATTLE, May 09, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will participate in the following upcoming investor conferences. A webcast and replay of each event will be available at ir.accolade.com. Thursday, May 12 at 1pm ET . BofA Securities ...
Accolade Launches Medication Integrated Care to Address Prescription Drug Costs and Complications PR Newswire Medication Integrated Care combines pharmacist-led medication therapy management with advanced analytics powered by Rx Savings Solutions to help employers reac...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the most impressive five-day charts in the market right now belongs to Accolade (NADSAQ: ACCD ). After falling approximately 50% in Friday’s session, shares of ACCD stock have rebounded in dramatic fashi...
Following a sharp selloff triggered by a disappointing outlook last week, the shares of Accolade (NASDAQ:ACCD) have bounced back on Monday after Wells Fargo upgraded the health services firm to Equal Weight from Underweight, citing a balanced risk/reward setup. With the earnings, Accolade (AC...
Gainers: Redbox Entertainment (RDBX) +48%. Blue Apron Holdings (APRN) +36%. Accolade (ACCD) +28%. Forge Global Holdings (FRGE) +22%. Hilltop Holdings (HTH) +19%. The Oncology Institute (TOI) +18%. OppFi (OPFI) +18%. Seer (SEER) +16%. Companhia Energetica de Minas Gerais (CIG) +16%. Silk Road ...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...